Taq polymerase

Taq polymerase
Jawahar Swaminathan and MSD staff at the European Bioinformatics Institute · Public domain · source
Name	Taq DNA polymerase
Organism	Thermus aquaticus
EC number	2.7.7.7
Length	~832 amino acids (full-length Pol I), thermostable fragment ~5'→3' polymerase domain
Optimum temperature	~72 °C (activity peak)
Cofactor	Mg2+

Taq polymerase Taq polymerase is a thermostable DNA-dependent DNA polymerase originally isolated from the thermophilic bacterium Thermus aquaticus and widely employed in polymerase chain reaction workflows. It enabled routine amplification of DNA in laboratories associated with institutions such as the Cold Spring Harbor Laboratory, Harvard University, Stanford University, and companies like Roche and Promega. The enzyme became central to techniques developed by researchers linked to Kary Mullis, Cetus Corporation, and diagnostic platforms at Centers for Disease Control and Prevention.

Overview

Taq polymerase functions as a DNA polymerase that synthesizes complementary DNA strands using a template-primer duplex and deoxynucleoside triphosphates; its thermostability allows thermal cycling used by developers at PerkinElmer and users at University of California, Berkeley to denature and reanneal templates. The enzyme’s robustness transformed workflows across laboratories at Massachusetts Institute of Technology, National Institutes of Health, Salk Institute, and Los Alamos National Laboratory, facilitating rapid amplification for researchers at Cold Spring Harbor Laboratory, Max Planck Society, Wellcome Trust, and numerous diagnostic companies. Regulatory and intellectual-property issues involving entities like Cetus Corporation, Hoffmann-La Roche, and courts influenced dissemination and commercial use.

Structure and biochemical properties

The polymerase derives from the chromosomal polA gene product of Thermus aquaticus and corresponds to a thermostable homolog of bacterial family A polymerases found in organisms such as Escherichia coli and Bacillus subtilis. Structural characterization by researchers at institutions like University of Wisconsin–Madison and University of California, San Diego revealed a right-hand architecture common to polymerases studied at European Molecular Biology Laboratory and Max Planck Institute labs. Crystallographic data produced by teams affiliated with Brookhaven National Laboratory and investigators who published in collaboration with Cold Spring Harbor Laboratory described polymerase subdomains termed thumb, fingers, and palm, analogous to structures reported for T7 DNA polymerase and E. coli DNA Polymerase I. Biochemically, the enzyme requires divalent cations such as Mg2+ or Mn2+, interacts with nucleotides analyzed in studies from Johns Hopkins University and Stanford University School of Medicine, and operates optimally near 72 °C as quantified in assays performed at European Molecular Biology Laboratory.

Mechanism of DNA synthesis and thermostability

The catalytic mechanism follows a two-metal-ion mechanism characterized in publications from groups at Max Planck Institute for Biophysical Chemistry and University of Cambridge, where nucleotidyl transfer is coordinated by active-site residues conserved with E. coli Pol I and viral polymerases like Phi29 DNA polymerase. Processivity and extension rates were assessed in laboratories at Cold Spring Harbor Laboratory and Harvard Medical School, showing extension of ~1 kb/min under typical buffer conditions developed by vendors such as Thermo Fisher Scientific. Thermostability arises from amino-acid substitutions and intra-protein interactions analogous to adaptations documented in extremophiles studied at Scripps Institution of Oceanography and University of Tokyo, and was further explored in comparative studies involving Pyrococcus furiosus polymerase and archaeal enzymes investigated at University of Oxford.

Applications in PCR and molecular biology

Taq polymerase underpins the polymerase chain reaction pioneered by Kary Mullis and commercialized by Cetus Corporation; it is used in genetic analyses in laboratories at National Institutes of Health, clinical diagnostics at Mayo Clinic and Mount Sinai Hospital, forensic workflows at FBI Laboratory, and research at universities including University of Cambridge and University of California, San Francisco. Applications encompass routine PCR, nested PCR protocols developed at Cold Spring Harbor Laboratory, and high-throughput assays in biotech firms like Illumina and Agilent Technologies. Taq-based assays were integrated into pathogen detection programs at World Health Organization, population genetics studies led by groups at University of Oxford, and environmental DNA surveys by teams at Smithsonian Institution.

Production, purification, and recombinant variants

Commercial production shifted from extraction from Thermus aquaticus to recombinant expression in hosts like Escherichia coli, with purification processes developed by companies such as Qiagen and NEB and academic groups at University of Illinois Urbana–Champaign. Recombinant variants and hot-start formulations were engineered using techniques from labs at Stanford University and Massachusetts General Hospital, and marketed by firms including Promega, Roche, and Thermo Fisher Scientific. Engineered high-fidelity and fusion constructs drawing on work from University of Wisconsin–Madison and Peking University combine domains or mutations inspired by polymerases from Pyrococcus abyssi and other extremophiles studied at University of Tokyo.

Limitations, fidelity, and error rates

Taq polymerase exhibits a relatively higher error rate than archaeal family B polymerases characterized by researchers at European Molecular Biology Laboratory and University of Cambridge, leading to incorporation errors documented in studies from Johns Hopkins University. Error-prone synthesis affects applications requiring high fidelity, prompting use of proofreading polymerases from Pyrococcus furiosus and vendors like New England Biolabs or use of proofreading blends devised at Cold Spring Harbor Laboratory and commercialized by Roche. Limitations such as lack of 3'→5' exonuclease activity influence cloning and sequencing projects at institutions including Wellcome Sanger Institute and Broad Institute.

History and discovery

Discovery of the enzyme occurred during exploration of thermophiles by researchers at Yellowstone National Park and microbiologists affiliated with University of California, Los Angeles and University of Idaho, culminating in isolation of Thermus aquaticus strains. The practical impact was realized through collaborations between academics and industry, notably Kary Mullis at Cetus Corporation and commercialization activities involving Hoffmann-La Roche and PerkinElmer. Patent disputes and licensing decisions implicated institutions such as University of California and affected dissemination across companies like Roche and Bio-Rad Laboratories, shaping molecular biology in the late 20th century and influencing awards and recognition connected to figures at Cold Spring Harbor Laboratory and National Academy of Sciences.

Category:DNA polymerases